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Abstract
Isolated central nervous system (CNS) vasculitis is a rare and complicated disorder.
Patients typically present with nonspeciﬁc neurologic symptoms such as headache
andencephalopathy,andhavevariableprogressionandseverityofthedisease.Chal-
lengestodeﬁnitivediagnosisincludethelimitationsofcurrentlyavailablediagnostic
modalitieswithhighlikelihoodoffalse-positiveorfalse-negativeﬁndings.Imaging,
serologic, and cerebrospinal ﬂuid (CSF) evaluation, and even angiography can fail
toestablishthediagnosis.Often,brainbiopsyisrequired.Inordertoillustratethese
challenges, we report the case of a patient who presented with subacute cognitive
decline and was ultimately diagnosed with isolated CNS eosinophilic vasculitis.
Initial work-up included CSF and serologic analyses, magnetic resonance imaging
(MRI), and cerebral angiography, but deﬁnitive diagnosis required brain biopsy.
Immunosuppressive therapy resulted in clinical improvement and stabilization. To
ourknowledge,onlyoneothercaseofisolatedCNSeosinophilicvasculitishasbeen
reported in the literature. We discuss the importance of a high index of clinical
suspicion in cases of progressive nonspeciﬁc neurologic symptoms.
Introduction
Central nervous system (CNS) vasculitis is a rare and diag-
nostically challenging disorder because patients present with
nonspeciﬁc symptoms of variable severity and progression,
such as headache and encephalopathy (Scolding 2009). Vas-
culitis isolated to the CNS is even less common than sys-
temicvasculitisandmaylackmanyofthediagnosticmarkers
(i.e.,elevatederythrocytesedimentationrate)seeninthelat-
ter (Moore 1989; Panda et al. 2000). Additionally, isolated
CNS vasculitis may mimic other disorders, such as infec-
tion, malignancy, or prion disease, which have overlapping
symptomatology. Deﬁnitive diagnosis is further complicated
becausemanydiagnosticmeasures,includingmagneticreso-
nance imaging (MRI) and cerebral angiography can produce
both false-positive and false-negative results for CNS vas-
culitis (Hankey 1991; Scolding 2009; Gomes). In many cases,
brain biopsy is the only useful diagnostic study. However,
even a negative brain biopsy does not rule out isolated CNS
vasculitis (Chu et al. 1998; Birnbaum and Hellmann 2009).
Based on published studies, the estimated sensitivity of cere-
bral angiography for detection of vasculitis is between 27%
and 90% (Calabrese and Mallek 1988; Vollmer et al. 1993;
Duna and Calabrese 1995; Chu et al. 1998; Alrawi et al. 1999;
Salvaranietal.2007;BirnbaumandHellmann2009)andthat
ofbrainbiopsybetween36%and83%(CalabreseandMallek
1988; Lie 1992; Duna and Calabrese 1995; Chu et al. 1998;
Salvaranietal.2007;BirnbaumandHellmann2009).Thus,a
high level of clinical suspicion is needed to make this elusive
diagnosis. To illustrate these challenges, we report a case of a
patient who presented with nonspeciﬁc symptoms and neg-
ative initial work up, in whom a brain biopsy was ultimately
neededtodiagnoseisolatedCNSeosinophilicvasculitis.This
case serves to emphasize the need for aggressive work up in
cases of suspected isolated CNS vasculitis, with willingness
to pursue brain biopsy when the diagnosis is not clear.
Presentation of Case
A 52-year-old right-handed woman presented to the emer-
gency room with progressive short-term memory loss and
word-ﬁnding difﬁculty. The symptoms began insidiously
3 months prior to her presentation to our institution with
disorientation to person and place, impaired naming, and
c   2011 The Authors. Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative
Commons Attribution Non-Commercial License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited and is not used for commercial purposes.
57Isolated CNS Vasculitis A. W. Amara et al.
poor balance. Three weeks before admission, she worsened
relatively rapidly with additional symptoms of personality
changeandcomprehensiondifﬁculties.Shedeniedanyweak-
ness or numbness, but complained of frontal headaches that
she was unable to further characterize. Comprehensive re-
view of symptoms was essentially negative, including no up-
per respiratory symptoms, fever, night sweats, arthralgias, or
rash.
Her past medical history included hypertension, diabetes,
hyperlipidemia, and chronic hearing loss. She did not have a
historyofmigraineheadachesorasthma.Hermedicationson
admission included insulin glargine, pravastatin, benazepril,
and metformin. The patient had previously worked in an
ofﬁce and denied any chemical or toxin exposures. She had a
40pack-yearhistoryofsmoking,havingquit20yearspriorto
presentation.Therewasnofamilyhistoryofcognitivedeﬁcit.
She was afebrile and had normal vital signs and general
physical exam. On neurologic examination, she was awake
and alert but oriented only to self. She was unable to name
a watch or pen and could not follow multistep commands.
There was no dysarthria, although she did display bradylalia.
Cranial nerves were normal except for decreased hearing to
ﬁngerrubbilaterally.Motor,sensory,andcoordinationexams
were normal. Deep tendon reﬂexes were normal throughout
with ﬂexor plantar responses. Unstressed gait was narrow
based with slightly unsteady tandem gait.
Noncontrast computed tomography (CT) of the head at
presentation showed bilateral (left greater than right) tem-
poral lobe hypodensities and diffuse atrophy (Fig. 1). The
patient was admitted for further evaluation.
Diagnosis
Based on the clinical presentation and imaging ﬁndings,
the patient was empirically started on acyclovir in the
emergency room, although the duration of her symptoms
made Herpes encephalitis unlikely. The differential diag-
nosis for subacute cognitive decline is very broad and in-
cludes infections (human immunodeﬁciency virus [HIV],
tuberculosis, neurosyphilis); primary CNS tumor includ-
ing CNS lymphoma, or metastasis; multifocal infarcts;
inﬂammatory/inﬁltrative processes such as sarcoidosis;
vasculitis; demyelinating disease (progressive multifocal
leukoencephalopathy, acute disseminated encephalomyeli-
tis); neurodegenerativedisease such as progressive dementia;
prion disease; paraneoplastic limbic encephalitis; and expo-
s u r e st ot o x i n ss u c ha so r g a n i cs o l v e n t s .T h i si n i t i a lb r o a d
differential is common in patients ultimately diagnosed with
isolated CNS vasculitis secondary to the nonspeciﬁc neuro-
logic symptoms.
In this patient, an MRI of the brain with and without
contrastshowedT2/FLAIRhyperintenseandT1hypointense
lesionsinthebilaterallateraltemporallobes(leftgreaterthan
right) with enhancement and restriction of diffusion in a
gyriform pattern (Fig. 2). Magnetic Resonance Angiography
(MRA) of the head and neck were normal.
Cerebrospinal ﬂuid (CSF) examination showed 1 white
blood cell, 148 red blood cells without xanthochromia, pro-
tein 61 mg/dL, and glucose 123 mg/dL. Herpes Simplex
Virus (HSV) polymerase chain reaction (PCR), venereal
disease research laboratory (VDRL), cryptococcal antigen,
Gram stain, bacterial and fungal cultures, toxoplasma anti-
gen,arbovirusPCR,WestNileVirusPCR,andvaricellazoster
PCR were all negative. Cytology and ﬂow cytometry could
not be performed on the CSF because there were too few
cells. CSF and serum angiotensin converting enzyme lev-
els were normal. Other normal or negative laboratory val-
ues included antinuclear antibody, erythrocyte sedimenta-
tion rate, cytomegalovirus IgG, rheumatoid factor, Sjogren’s
antibodies (SSA and SSB), cytoplasmic and perinuclear
Figure 1. CT head upon presentation.
Noncontrast CT of the head showing
bilateral temporal hypodensities, left greater
than right.
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Figure 2. MRI brain. (A) Diffusion weighted image-revealing restriction
of diffusion in gyriform pattern in bilateral temporal lobes, worse on the
left, conﬁrmed with apparent diffusion coefﬁcient map (B). (C) FLAIR
image showing hyperintesities in bilateral lateral temporal lobes. (D)
Gyriform pattern of enhancement on postcontrast T1 image.
antineutrophil cytoplasmic antibodies (c-ANCA and p-
ANCA), immunoﬁxation electrophoresis, serum protein
electrophoresis, urine protein electrophoresis, HIV, renal
function, liver function, electrolytes, urine drug screen, and
complete blood count with differential.
CT of the chest, abdomen, and pelvis demonstrated no
evidence of lymphoma or primary malignancy. Long-term
video EEG was normal. A four-vessel cerebral angiogram
was normal without any evidence of vasculitis.
Because of the patient’s continued symptoms and un-
clear diagnosis, the patient underwent a brain biopsy of the
left anterior temporal lobe. Histopathological examination
demonstrated a chronic astrogliosis of the gray matter with-
outinﬂammation.Theleptomeningescontaineddilatedves-
sels with neutrophils and eosinophils. Some vessel walls had
been destroyed by the eosinophilic inﬂammation; both ar-
teries and veins were involved. There were no granulomas or
giantcells.Congoredstainingdidnotshowevidenceofamy-
loid deposition in the vessels. These ﬁndings were consistent
with eosinophilic vasculitis (Fig. 3). No parasitic or amebic
organisms were seen. Review of her peripheral blood smear
showed no peripheral eosinophilia.
Treatment
The patient received high-dose glucocorticoid therapy with
1-g methylprednisolone intravenously once a day for 5 days.
During that initial treatment, her language and memory im-
proved, and she regained the ability to recognize and name
family members. She also became oriented to person, place,
andtime,andhernamingabilityrecovered.Hercomprehen-
sion improved but she remained unable to perform complex
tasks.Shewassubsequentlyplacedonaprolongedoralpred-
nisone taper and continued to have some mild additional
improvement in cognition over the next month. The pa-
tient was then started on oral cyclophosphamide (2 mg/kg)
and her symptoms have remained stable through follow-up
over 2 years. She was monitored closely for bone marrow
suppressionassociatedwithcyclophosphamide.After2years
of cyclophosphamide administration, she developed micro-
scopic hematuria despite aggressive hydration. A cystoscopy
was negative for transitional cell carcinoma. Oral cyclophos-
phamide therapy was discontinued and she has continued to
remain clinically stable.
Figure 3. Brain biopsy. The vessel walls are
obliterated by chronic inﬂammatory cells,
the majority of which are eosinophils. Yellow
Asterisk = vascular lumen; Red Asterisk =
vessel wall. (A) H&E × 200. (B) H&E × 1000.
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Discussion
This case serves to illustrate the diagnostic challenges of iso-
lated CNS vasculitis. This entity is difﬁcult to deﬁne clini-
cally because its presentation is so variable. Vasculitis must
therefore remain in the differential diagnosis in cases with
nonspeciﬁcneurologicdeclinewherenootheretiologyisap-
parent. In this case, brain biopsy was required to make the
diagnosis. The decision to pursue brain biopsy should be
consideredwhenthediagnosisisnotclear.Angiographymay
appearnormal,aswasthecaseinourpatient,eveninthepres-
ence of biopsy or autopsy proven CNS vasculitis (Alrawi et
al. 1999). Alternatively, other conditions such as vasospasm
or atherosclerosis (Duna and Calabrese 1995) may mimic
vasculitis on a cerebral angiogram. In fact, the estimated
speciﬁcity of angiography for detecting vasculitis is between
14% and 60% (Chu et al. 1998; Kadkhodayan et al. 2004)
and that of MRI is between 19% and 36% (Calabrese and
Duna1995;DunaandCalabrese1995;Chuetal.1998),while
that of brain biopsy is between 87% and 100% (Duna and
Calabrese1995;Chuetal.1998).Anadditionalroleforbiopsy
in these cases is to rule out alternative diagnoses, such as
CNS lymphoma or infection, for which incorrect or delayed
treatment could lead to poor outcome. The most commonly
encountered risk associated with stereotactic brain biopsy is
hemorrhage, the incidence of which ranges from 8 to 9%,
with 1–4% of these hemorrhages being symptomatic (Field
etal.2001;McGirtetal.2005).Overallmortalityandmorbid-
ity have been estimated at 0.7% and 3.5%, respectively (Hall
1998).Ineachcase,theriskofbrainbiopsyshouldbeweighed
against potential for incorrect diagnosis or continued/
progressive neurologic disability.
The etiology of this particular case of isolated CNS
eosinophilic vasculitis is unclear. The patient did not have
peripheral eosinophilia as would be expected if the vasculi-
tis were secondary to a hypersensitivity allergic reaction or
parasitic infection and there were no parasites or amebae
seen on brain biopsy. Hypereosinophilic syndrome (HES),
deﬁned as blood and/or tissue eosinophilia without under-
lying allergic, parasitic, or other cause (Sheikh and Weller
2009) is a possible diagnosis. Neurologic manifestations in
combination with systemic disease are common in HESs
(∼50%)(SheikhandWeller,2007).Churg-Strausssyndrome
(CSS) is an HES associated with peripheral eosinophilic vas-
culitis that may also be associated with neurologic symp-
toms (∼60%) (Sehgal et al. 1995). However, diagnosis of
CSS requires four of the following six diagnostic criteria:
asthma, peripheral eosinophilia >10%, mono- or polyneu-
ropathy, pulmonary inﬁltrates, paranasal sinus abnormality,
and extravascular eosinophils (Masi et al. 1990). Our patient
did not meet these criteria. Additionally, CSS is character-
ized by granulomatous eosinophilic vasculitis, and granulo-
mata were absent in the biopsy specimen obtained from our
patient. There have been case reports of “limited” CSS with
eosinophilic vasculitis or extravascular granulomas in the
absence of blood eosinophilia or asthma. These cases have
included vasculitic involvement of the skin and eyes (Khan
et al. 1996), lungs (Sevinc et al. 2004), kidneys (Sharma et al.
2004), and heart (Taira et al. 2005). There has also been one
previous report of isolated CNS eosinophilic vasculitis in the
absence of asthma or peripheral eosinophilia (Sommerville
et al. 2007). As in our case, the patient reported by
Sommerville et al. had absence of granulomata or amy-
loid on biopsy and imaging ﬁndings were similar in the
two cases. Both cases required brain biopsy for deﬁnitive
diagnosis (Sommerville et al. 2007), suggesting that isolated
CNS eosinophilic vasculitis may be an underrecognized en-
tity within the spectrum of HESs.
An alternative diagnosis is primary angiitis of the CNS
(PACNS). The diagnostic criteria of this entity include:
(1) unexplained neurologic deﬁcit after thorough clinical
and laboratory evaluation; (2) evidence of an arteritic pro-
cess by cerebral angiography and/or tissue examination; and
(3) no evidence of a systemic vasculitis or any other condi-
tion to which the angiographic or pathologic ﬁndings could
be secondary (Calabrese and Mallek 1988). The presence of
eosinophils is unusual for this condition, arguing against
classiﬁcation of this case as deﬁnite PACNS.
In summary, this case of isolated CNS eosinophilic vas-
culitis demonstrates the difﬁculty encountered in establish-
ing a diagnosis in cases of isolated CNS vasculitis in patients
with subacute cognitive decline. Despite extensive labora-
tory, imaging, and angiographic evaluation, diagnosis often
requires brain biopsy. This potentially neurologically devas-
tating disorder istreatablewith immunosuppressanttherapy
and therefore deﬁnitive diagnosis is critical. A relatively high
index of suspicion and willingness to pursue a brain biopsy
is often necessary to diagnose isolated CNS vasculitis.
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